Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006773290> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2006773290 endingPage "252S" @default.
- W2006773290 startingPage "252S" @default.
- W2006773290 abstract "S252 Remifentanil is a new ultrashort-acting anilidopiperidine with a [micro sign]-specific opioid action. Remifentanil with its unique properties could be of particular use for fetal and maternal analgesia during fetal surgery. However, the hemodynamic changes and pharmacokinetic behavior of remifentanil in the pregnant patient have not been studied in depth. METHODS: Using the chronic maternal-fetal sheep preparation, a continuous infusion of remifentanil 0.33 [micro sign]g/kg/min was administered intravenously over 60 min. Fetal and maternal arterial blood samples were obtained for remifentanil levels before and at 5, 15, 30, 60, 65, 75 and 120 min following start of the infusion. At regular intervals, arterial blood samples were drawn to determine blood gases and acid-base status of mother and fetus. Maternal mean arterial pressure (MMAP), uterine bloodflow (UBF), maternal heart rate (MHR), fetal mean arterial pressure (FMAP) and fetal heart rate (FHR) were recorded continuously. Statistical analyses were performed using repeated measures of ANOVA followed by Dunnett t-testing. A p value < 0.05 was considered significant. RESULTS: Eight experiments were performed in eight ewes. MMAP, MHR FHR, FMAP and UBF or blood-gases and acid-base status in mother or fetus did not change significantly during remifentanil infusion. Peak levels of remifentanil were detected in maternal plasma after 30 min. and reached 3.5 ng/ml. Peak fetal plasma levels of 0.36 ng/ml were attained after 60 min. (Figure 1)Figure 1CONCLUSION: This study indicates that intravenous aplication of remifentanil has not any significant effect on maternal and fetal cardiovascular and acid-base status in the pregnant ewe. Peak fetal plasma concentration of remifentanil reached 14% of the peak maternal placental concentration." @default.
- W2006773290 created "2016-06-24" @default.
- W2006773290 creator A5000244991 @default.
- W2006773290 creator A5005597117 @default.
- W2006773290 creator A5012034106 @default.
- W2006773290 creator A5018281416 @default.
- W2006773290 creator A5064712709 @default.
- W2006773290 date "1999-02-01" @default.
- W2006773290 modified "2023-09-23" @default.
- W2006773290 title "HEMODYNAMIC EFFECTS AND PLACENTAL TRANSFER AFTER CONTINUOUS INTRAVENOUS APPLICATION OF REMIFENTANIL IN THE CHRONIC MATERNAL-FETAL SHEEP PREPARATION" @default.
- W2006773290 doi "https://doi.org/10.1097/00000539-199902001-00251" @default.
- W2006773290 hasPublicationYear "1999" @default.
- W2006773290 type Work @default.
- W2006773290 sameAs 2006773290 @default.
- W2006773290 citedByCount "5" @default.
- W2006773290 crossrefType "journal-article" @default.
- W2006773290 hasAuthorship W2006773290A5000244991 @default.
- W2006773290 hasAuthorship W2006773290A5005597117 @default.
- W2006773290 hasAuthorship W2006773290A5012034106 @default.
- W2006773290 hasAuthorship W2006773290A5018281416 @default.
- W2006773290 hasAuthorship W2006773290A5064712709 @default.
- W2006773290 hasBestOaLocation W20067732901 @default.
- W2006773290 hasConcept C112705442 @default.
- W2006773290 hasConcept C126322002 @default.
- W2006773290 hasConcept C172680121 @default.
- W2006773290 hasConcept C178853913 @default.
- W2006773290 hasConcept C2776277131 @default.
- W2006773290 hasConcept C2776452961 @default.
- W2006773290 hasConcept C2777953023 @default.
- W2006773290 hasConcept C2778891214 @default.
- W2006773290 hasConcept C2779234561 @default.
- W2006773290 hasConcept C2779537118 @default.
- W2006773290 hasConcept C42219234 @default.
- W2006773290 hasConcept C43044207 @default.
- W2006773290 hasConcept C54355233 @default.
- W2006773290 hasConcept C71924100 @default.
- W2006773290 hasConcept C84393581 @default.
- W2006773290 hasConcept C86803240 @default.
- W2006773290 hasConceptScore W2006773290C112705442 @default.
- W2006773290 hasConceptScore W2006773290C126322002 @default.
- W2006773290 hasConceptScore W2006773290C172680121 @default.
- W2006773290 hasConceptScore W2006773290C178853913 @default.
- W2006773290 hasConceptScore W2006773290C2776277131 @default.
- W2006773290 hasConceptScore W2006773290C2776452961 @default.
- W2006773290 hasConceptScore W2006773290C2777953023 @default.
- W2006773290 hasConceptScore W2006773290C2778891214 @default.
- W2006773290 hasConceptScore W2006773290C2779234561 @default.
- W2006773290 hasConceptScore W2006773290C2779537118 @default.
- W2006773290 hasConceptScore W2006773290C42219234 @default.
- W2006773290 hasConceptScore W2006773290C43044207 @default.
- W2006773290 hasConceptScore W2006773290C54355233 @default.
- W2006773290 hasConceptScore W2006773290C71924100 @default.
- W2006773290 hasConceptScore W2006773290C84393581 @default.
- W2006773290 hasConceptScore W2006773290C86803240 @default.
- W2006773290 hasIssue "2S" @default.
- W2006773290 hasLocation W20067732901 @default.
- W2006773290 hasLocation W20067732902 @default.
- W2006773290 hasOpenAccess W2006773290 @default.
- W2006773290 hasPrimaryLocation W20067732901 @default.
- W2006773290 hasRelatedWork W2109477635 @default.
- W2006773290 hasRelatedWork W2275351898 @default.
- W2006773290 hasRelatedWork W2348423746 @default.
- W2006773290 hasRelatedWork W2382733544 @default.
- W2006773290 hasRelatedWork W2416094913 @default.
- W2006773290 hasRelatedWork W2615356009 @default.
- W2006773290 hasRelatedWork W2912123072 @default.
- W2006773290 hasRelatedWork W299146927 @default.
- W2006773290 hasRelatedWork W3016748865 @default.
- W2006773290 hasRelatedWork W4224326175 @default.
- W2006773290 hasVolume "88" @default.
- W2006773290 isParatext "false" @default.
- W2006773290 isRetracted "false" @default.
- W2006773290 magId "2006773290" @default.
- W2006773290 workType "article" @default.